Digital pill is within reach, the incumbent question now is how it could affect or revolutionize health care in the world?
US Food and Drug Administration has approved the first ‘digital pill’ in the world.
U.S. FDA regulators just greenlighted a tiny, swallowable sensor called Abilify MyCite that tracks when the patient takes their meds.
The tablet is specifically targeted to people with mental health conditions like schizophrenia and bipolar disorder and is the first of its kind to get approved.
Digital pills, which typically include a sensor about the size of a grain of sand, can travel safely through the body and communicate with some kind of external device, like an app or a wearable patch.
The new method aims to solve a big and expensive problem: Patients not taking their meds on time, or at all.
Based on CNBC report, the pill could cut costs taxpayers somewhere in the realm of $100 billion to $289 billion a year in the U.S. alone.
To put things simple to digest, when patients don’t get their scripts filled or finish a dose, their symptoms get worse and they often end up in the hospital.
Also, the hope for this new category of technology is to provide health providers with a GPS tracking system of sorts for the human body. By tracking a patient’s compliance with their regimen, rather than relying on what they self-report, they can nudge them if needed.
A funtastic way of dealing health problems, easing the burden of the government and offering a healthier world.
According to eports, another big-picture goal and edge for digital pills is to better tailor or personalize medications for patients.
Digital pills are designed to augment traditional therapies. But some in the medical community believe that tech can someday replace pills altogether — a category sometimes referred to as “digital therapeutics.”
Furthermore, digital therapeutics goes beyond sensor-laden pills to include other digital elements, like coaching via a mobile app to help a patient achieve a better health outcome.
As of the moment, several health companies has already embark on digital-based approach in dealing health issues as an example, one company named Propeller Health, has a program for people with chronic respiratory disease that includes a mobile app and a rescue inhaler packed with sensors.
The idea is that Propeller can track which patients aren’t taking their controller meds frequently enough, and alert them to that fact. The company also looks at external triggers, such as weather events and air quality.
If we could see the logic here, these technologies tend to have a clear business model, if they can prove that they work.
Propeller’s solution is compelling for pharmacy benefits managers, insurers and pharmaceutical companies, which are all looking for ways to make medications more effective and prevent costly health outcomes like a trip to the emergency room.